# FRANCO NEVADA Corp: financial statements, quarterly

FNV · NYSE · CIK 1456346 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fnv.md) · [Financials](/companies/fnv/financials.md) · [Filings](/companies/fnv/filings.md) · [Insiders](/companies/fnv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fnv/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [149](/filings/0001558370-18-002485.md) | [253](/filings/0001558370-19-002489.md) | [511](/filings/0001558370-20-002894.md) | [69.7](/filings/0001558370-21-003216.md) | [132](/filings/0001558370-22-003864.md) | [534](/filings/0001558370-23-004112.md) | [539](/filings/0001558370-24-003443.md) | [1,197](/filings/0001558370-25-003388.md) | [1,422](/filings/0001104659-26-032133.md) | [1,451](/filings/0001104659-26-032133.md) | [671](/filings/0001104659-26-032133.md) |
| Current assets | $m | not reported | [361](/filings/0001558370-18-002485.md) | [616](/filings/0001558370-19-002489.md) | [179](/filings/0001558370-20-002894.md) | [279](/filings/0001558370-21-003216.md) | [664](/filings/0001558370-22-003864.md) | [751](/filings/0001558370-23-004112.md) | [1,383](/filings/0001558370-24-003443.md) | [1,615](/filings/0001558370-25-003388.md) | [1,717](/filings/0001104659-26-032133.md) | [1,021](/filings/0001104659-26-032133.md) |
| Total assets | $m | not reported | [4,222](/filings/0001558370-18-002485.md) | [4,788](/filings/0001558370-19-002489.md) | [4,932](/filings/0001558370-20-002894.md) | [5,281](/filings/0001558370-21-003216.md) | [5,593](/filings/0001558370-22-003864.md) | [6,210](/filings/0001558370-23-004112.md) | [6,627](/filings/0001558370-24-003443.md) | [5,994](/filings/0001558370-25-003388.md) | [6,330](/filings/0001104659-26-032133.md) | [8,241](/filings/0001104659-26-032133.md) |
| Current liabilities | $m | not reported | [37.6](/filings/0001558370-18-002485.md) | [22.6](/filings/0001558370-19-002489.md) | [25.0](/filings/0001558370-20-002894.md) | [53.4](/filings/0001558370-21-003216.md) | [53.2](/filings/0001558370-22-003864.md) | [43.2](/filings/0001558370-23-004112.md) | [50.2](/filings/0001558370-24-003443.md) | [39.2](/filings/0001558370-25-003388.md) | [67.5](/filings/0001104659-26-032133.md) | [123](/filings/0001104659-26-032133.md) |
| Total liabilities | $m | not reported | [75.1](/filings/0001558370-18-002485.md) | [82.9](/filings/0001558370-19-002489.md) | [300](/filings/0001558370-20-002894.md) | [218](/filings/0001558370-21-003216.md) | [149](/filings/0001558370-22-003864.md) | [185](/filings/0001558370-23-004112.md) | [209](/filings/0001558370-24-003443.md) | [225](/filings/0001558370-25-003388.md) | [334](/filings/0001104659-26-032133.md) | [606](/filings/0001104659-26-032133.md) |
| Shareholders' equity | $m | [3,163](/filings/0001558370-18-002485.md) | [4,147](/filings/0001558370-19-002489.md) | [4,706](/filings/0001558370-20-002894.md) | [4,632](/filings/0001558370-21-003216.md) | [5,062](/filings/0001558370-22-003864.md) | [5,444](/filings/0001558370-23-004112.md) | [6,025](/filings/0001558370-24-003443.md) | [6,418](/filings/0001558370-25-003388.md) | [5,769](/filings/0001104659-26-032133.md) | [5,997](/filings/0001104659-26-032133.md) | [7,635](/filings/0001104659-26-032133.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 192,798,692 at 2025-12-31, from the cover of the [40-F filed 2026-03-19](/filings/0001104659-26-032133.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.